See more : reAlpha Tech Corp. Common Stock (AIRE) Income Statement Analysis – Financial Results
Complete financial analysis of XWELL, Inc. (XWEL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of XWELL, Inc., a leading company in the Personal Products & Services industry within the Consumer Cyclical sector.
You may be interested
- Crédit Agricole S.A. (CRARF) Income Statement Analysis – Financial Results
- Aeeris Limited (AER.AX) Income Statement Analysis – Financial Results
- Genesis Energy, L.P. (GEL) Income Statement Analysis – Financial Results
- Biotech Acquisition Company (BIOT) Income Statement Analysis – Financial Results
- Zhejiang Asia-Pacific Mechanical & Electronic Co.,Ltd (002284.SZ) Income Statement Analysis – Financial Results
XWELL, Inc. (XWEL)
About XWELL, Inc.
XWELL Inc., a health and wellness services company, provides spa services at airports. It operates through XpresSpa, XpresTest, Treat, and HyperPointe brands. The company offers spa services, including massage, and nail and skin care, as well as spa and travel products; and retail products. It also operates wellness centers that provides COVID-19 screening and testing, and rapid testing services for other communicable diseases, such as influenza, COVID-19, RSV, Flu A&B, and seasonal flu vaccination services; and other medical diagnostic testing services. In addition, the company offers services through an integrated digital platform, and a relevant retail offering to the traveling public. As of December 31, 2021, it operated 52 spa and clinic locations in 24 airports in the United States, the Netherlands, and the United Arab Emirates. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL Inc. in October 2022. XWELL Inc. is headquartered in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 30.11M | 55.94M | 73.73M | 8.39M | 48.52M | 50.09M | 48.82M | 18.97M | 22.69M | 1.43M | 1.10M | 369.00K | 718.00K | 211.00K | 20.00K | 0.00 |
| Cost of Revenue | 26.43M | 43.89M | 41.30M | 11.98M | 37.85M | 39.45M | 39.34M | 12.82M | 19.35M | 25.37M | 21.59M | 12.51M | 155.00K | 180.00K | 31.00K | 0.00 |
| Gross Profit | 3.68M | 12.05M | 32.43M | -3.60M | 10.66M | 10.64M | 9.48M | 6.16M | 3.33M | -23.94M | -20.49M | -12.14M | 563.00K | 31.00K | -11.00K | 0.00 |
| Gross Profit Ratio | 12.23% | 21.54% | 43.98% | -42.91% | 21.97% | 21.25% | 19.42% | 32.44% | 14.70% | -1,680.21% | -1,862.73% | -3,290.79% | 78.41% | 14.69% | -55.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 681.00K | 92.00K | 889.00K | 1.51M | 1.74M | 2.02M | 2.36M | 1.98M | 3.11M |
| General & Administrative | 12.96M | 31.17M | 24.20M | 15.94M | 14.32M | 16.24M | 16.58M | 12.86M | 9.62M | 16.37M | 40.37M | 10.23M | 2.78M | 2.07M | 1.57M | 1.41M |
| Selling & Marketing | 7.95M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.25M | 163.00K | -889.00K | 0.00 | 659.00K | 2.19M | 2.10M | 1.75M | 2.77M |
| SG&A | 20.91M | 31.17M | 24.20M | 15.94M | 14.32M | 16.24M | 16.58M | 14.11M | 10.38M | 15.48M | 40.37M | 10.89M | 4.97M | 4.17M | 3.32M | 4.18M |
| Other Expenses | 10.98M | 5.43M | 3.20M | 5.21M | 6.12M | 498.00K | -197.00K | 681.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 31.89M | 36.60M | 27.40M | 21.15M | 20.44M | 25.74M | 24.55M | 28.57M | 13.68M | 21.50M | 41.88M | 12.63M | 6.99M | 6.53M | 5.30M | 7.29M |
| Cost & Expenses | 58.32M | 80.49M | 68.70M | 33.13M | 58.30M | 65.19M | 63.90M | 41.39M | 33.03M | 46.86M | 41.88M | 25.14M | 7.14M | 6.71M | 5.33M | 7.29M |
| Interest Income | 448.00K | 384.00K | 43.00K | 1.83M | 2.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 321.00K | 16.13M | 0.00 | 1.83M | 2.90M | 1.83M | 731.00K | 1.70M | 2.59M | 0.00 | 0.00 | 0.00 | 1.53M | 4.30M | 617.00K | 157.00K |
| Depreciation & Amortization | 3.55M | 7.27M | 4.92M | 7.23M | 6.12M | 9.50M | 6.85M | 1.32M | 3.52M | 4.02M | 5.22M | 2.50M | 61.00K | 87.00K | 113.00K | 107.00K |
| EBITDA | -15.75M | -19.12M | 7.87M | -19.54M | -11.24M | -24.58M | -8.43M | -16.26M | -6.01M | -40.32M | -35.56M | -19.87M | -5.80M | -6.41M | -5.35M | -7.18M |
| EBITDA Ratio | -52.31% | -16.77% | 14.63% | -198.75% | -11.46% | -10.18% | -14.94% | -45.51% | -30.10% | 1,646.81% | -3,144.18% | -6,034.42% | -886.21% | -3,036.97% | -25,965.00% | 0.00% |
| Operating Income | -19.30M | -24.55M | 5.87M | -40.10M | -9.78M | -34.73M | -15.07M | -22.42M | -10.34M | -111.20M | -40.78M | -24.77M | -6.42M | -6.50M | -5.31M | -7.29M |
| Operating Income Ratio | -64.08% | -43.89% | 7.95% | -478.28% | -20.16% | -69.32% | -30.87% | -118.15% | -45.59% | -7,803.23% | -3,707.00% | -6,712.20% | -894.71% | -3,078.20% | -26,530.00% | 0.00% |
| Total Other Income/Expenses | -8.70M | -1.41M | -1.16M | -52.12M | -4.80M | -1.18M | -1.29M | -1.57M | -1.78M | 1.97M | -971.00K | 1.59M | -965.00K | -3.41M | -770.00K | -51.00K |
| Income Before Tax | -27.99M | -32.57M | 3.03M | -92.23M | -20.68M | -35.91M | -16.00M | -24.00M | -12.12M | -109.22M | -41.75M | -20.79M | -7.39M | -9.91M | -6.08M | -7.34M |
| Income Before Tax Ratio | -92.98% | -58.23% | 4.11% | -1,099.88% | -42.62% | -71.68% | -32.77% | -126.50% | -53.44% | -7,664.70% | -3,795.27% | -5,633.06% | -1,029.11% | -4,695.26% | -30,380.00% | 0.00% |
| Income Tax Expense | 35.00K | 55.00K | 140.00K | 7.00K | -146.00K | -278.00K | 111.00K | 13.64M | -866.00K | 65.34M | 11.66M | 55.00K | 90.00K | 35.00K | 73.00K | -7.00K |
| Net Income | -27.74M | -32.63M | 3.35M | -92.23M | -20.53M | -37.21M | -28.84M | -24.01M | -11.16M | -109.68M | -52.43M | -20.84M | -7.48M | -9.94M | -6.15M | -7.33M |
| Net Income Ratio | -92.14% | -58.33% | 4.54% | -1,099.96% | -42.32% | -74.27% | -59.07% | -126.52% | -49.18% | -7,696.63% | -4,766.64% | -5,647.97% | -1,041.64% | -4,711.85% | -30,745.00% | 0.00% |
| EPS | -6.64 | -6.97 | 0.60 | -41.39 | -251.22 | -1.54K | -1.55K | -1.90K | -1.31K | -14.68K | -7.56K | -6.39K | -9.02K | -22.09K | -2.57 | -7.02K |
| EPS Diluted | -6.64 | -6.97 | 0.60 | -41.39 | -251.22 | -1.54K | -1.55K | -1.90K | -1.31K | -14.55K | -7.56K | -6.00K | -9.02K | -22.09K | -2.57 | -7.02K |
| Weighted Avg Shares Out | 4.18M | 4.68M | 5.22M | 2.23M | 81.72K | 24.23K | 18.57K | 12.64K | 8.51K | 7.47K | 6.93K | 3.26K | 829.00 | 450.00 | 2.39M | 1.05K |
| Weighted Avg Shares Out (Dil) | 4.18M | 4.68M | 5.25M | 2.23M | 81.72K | 24.23K | 18.57K | 12.64K | 8.51K | 7.54K | 6.94K | 3.47K | 829.00 | 450.00 | 2.39M | 1.05K |
XWELL, Inc. Plans to File Form 12b-25 to Extend Filing Date of its Form 10-K
NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today announced plans to file a Form 12b-25 with the U.S. Securities and Exchange...
CDC Traveler-based Genomic Surveillance Program to Expand to Two New US International Airports in Miami and Chicago
The TGS program, a leading example of biosecurity infrastructure, operates at a total of nine US locations and leverages voluntary nasal swabs as well as wastewater sampling from international travelers to detect more than 30 pathogens. BOSTON, March 12, 2024...
XWELL Appoints Veteran Consumer & Wellness Entrepreneur Gaëlle Wizenberg to its Board of Directors
NEW YORK, Dec. 15, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today announced the appointment of Gaëlle Wizenberg to the Company's Board of Directors, effective...
XWELL Opens New XpresSpa Location in Abu Dhabi International Airport
Eleventh international wellness center is the latest move by XWELL to expand its global footprint Eleventh international wellness center is the latest move by XWELL to expand its global footprint
XWELL, Inc. Reports Third Quarter 2023 Results
Airport Spas Deliver Strong 39% Year-Over-Year Q3 Revenue Growth Naples Wax Center Acquisition Accelerates Future Off-Airport Growth Opportunities Further Airport Spa Expansion Internationally
Ginkgo Bioworks and XWELL Implement Expanded CDC Traveler-based Genomic Surveillance Program to Test for More than 30 Known Pathogens
The program can be an effective early warning system for public health and national security officials, leveraging voluntary nasal and wastewater sampling from international travelers at major U.S. airports BOSTON , Nov. 6, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA),...
Ginkgo Bioworks and XWELL Implement Expanded CDC Traveler-based Genomic Surveillance Program to Test for More than 30 Known Pathogens
The program can be an effective early warning system for public health and national security officials, leveraging voluntary nasal and wastewater sampling from international travelers at major U.S. airports The program can be an effective early warning system for public...
XWELL's CEO Scott Milford Discusses Strategic Growth Plans During Recent Investor Fireside Chat
Highlights the Recent Acquisition of Naples Wax Center as Launch Pad for XWELL's Out of Airport Strategy Highlights the Recent Acquisition of Naples Wax Center as Launch Pad for XWELL's Out of Airport Strategy
XWELL Celebrates Breast Cancer Awareness Month with Philanthropic Nail Care Program
Proceeds from select XpresSpa nail care services to be donated to Susan G. Komen Proceeds from select XpresSpa nail care services to be donated to Susan G. Komen
XWELL's CEO Scheduled to Present at Upcoming Investor Fireside Chat on October 4, 2023
Scott Milford to Present at Water Tower Research Fireside Chat Series on Wednesday, October 4, 2023, at 2:30 p.m. E.T. Scott Milford to Present at Water Tower Research Fireside Chat Series on Wednesday, October 4, 2023, at 2:30 p.m. E.T.
Source: https://incomestatements.info
Category: Stock Reports